---
layout: post
title: "Determination That NIPRIDE RTU (Sodium Nitroprusside), 10 Milligrams/50 Milliliters (0.2 Milligrams/Milliliters), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness"
date: 2026-02-05 19:08:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-05324
original_published: 2021-03-16 00:00:00 +0000
significance: 8.00
---

# Determination That NIPRIDE RTU (Sodium Nitroprusside), 10 Milligrams/50 Milliliters (0.2 Milligrams/Milliliters), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 16, 2021 00:00 UTC
**Document Number:** 2021-05324

## Summary

The Food and Drug Administration (FDA or Agency) has determined that NIPRIDE RTU (sodium nitroprusside), 10 milligrams (mg)/ 50 milliliters (mL) (0.2 mg/mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for sodium nitroprusside, 10 mg/50 mL (0.2 mg/mL), if all other legal and regulatory requirements are met.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/03/16/2021-05324/determination-that-nipride-rtu-sodium-nitroprusside-10-milligrams50-milliliters-02)
- API: https://www.federalregister.gov/api/v1/documents/2021-05324

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
